Urinary Retention MDM

Last reviewed: March 2026

Contents: Templates | Education | References

MDM Templates

Acute Urinary Retention — Discharge with Catheter

Patient presents with acute urinary retention. Well appearing without signs of sepsis. No history or exam findings suggestive of cauda equina, spinal cord compression, or intra-abdominal mass. Foley catheter placed with *** mL output. No gross hematuria or concern for bladder injury from overdistension. Plan: Discharge with indwelling catheter to leg bag. Tamsulosin 0.4 mg daily started. Disposition: Urology follow-up within 3-5 days for voiding trial. Return for fever, hematuria, or catheter malfunction.

Urinary Retention — Medication-Induced

Patient presents with acute urinary retention in setting of recent *** (opioid/anticholinergic/sympathomimetic) use. No neurologic deficits to suggest cauda equina. Foley catheter placed with relief. Plan: Discontinue or reduce offending medication if possible. Disposition: Discharge with catheter and urology follow-up for voiding trial after medication clearance.

Urinary Retention — Concern for Cauda Equina

Patient presents with urinary retention with associated saddle anesthesia, bilateral lower extremity weakness, and/or bowel dysfunction. Presentation concerning for cauda equina syndrome. MRI spine obtained emergently. Neurosurgery consulted. Disposition: Admit for emergent surgical decompression if confirmed.

Clinical Education

Causes of Acute Urinary Retention

The etiology of acute urinary retention varies significantly between sexes and age groups. In men, benign prostatic hyperplasia (BPH) is the most common cause, followed by medication-induced retention (opioids, anticholinergics, tricyclic antidepressants, sympathomimetic decongestants). In women, acute retention is less common but may result from pelvic mass (fibroids, ovarian cyst), pelvic floor dysfunction, or urethral obstruction. Neurologic causes — such as multiple sclerosis, spinal cord injury, or cauda equina syndrome — must be recognized urgently in any patient presenting with retention plus neurologic symptoms. Medications should always be reviewed; in particular, high-dose opioids and anticholinergics are frequent culprits in the acute setting. Urinalysis and post-void residual assessment by bladder scan or catheterization can help quantify the degree of retention^[1].

Catheterization Pearls

Successful catheterization requires familiarity with different catheter types and a systematic approach to difficult cases. Standard Foley catheters are appropriate for most patients with uncomplicated retention. Coude tip (angled) catheters are reserved for patients with suspected prostatic obstruction, urethral stricture, or difficulty passing a standard catheter, as the angle facilitates passage through or around an obstructing lesion. If standard catheterization fails, attempt the coude; if this also fails, consult urology for flexible cystoscopy (gold standard for diagnosis and treatment) or suprapubic catheterization. Never force a catheter, as this risks urethral perforation. A “cannot catheterize” algorithm should prioritize coude attempt, then urology consultation for cystoscopic placement or suprapubic catheterization; the emergency provider should not attempt multiple aggressive passes^[2].

Post-Obstructive Diuresis

Large-volume catheterization (typically >1500 mL on initial drain) may trigger post-obstructive diuresis, requiring careful monitoring and fluid management. This polyuria can result in significant fluid and electrolyte losses, particularly of sodium and potassium. Patients who experience brisk diuresis (>200 mL/hour) following catheter placement should have serum electrolytes rechecked within a few hours and urine output monitored closely. Fluid replacement should be conservative — replacing approximately half of measured urine output with normal saline to avoid hyponatremia — and should be titrated based on clinical status and repeat electrolyte assessment. Some patients require intensive monitoring for hyperkalemia or hypokalemia depending on the degree of diuresis and underlying renal function. Close follow-up with urology is essential for reassessment and planned voiding trial^[1].

Cauda Equina Red Flags

Urinary retention combined with saddle anesthesia and bilateral lower extremity weakness is cauda equina syndrome until proven otherwise. Cauda equina is a neurosurgical emergency requiring emergent MRI and surgical decompression within hours to prevent permanent neurologic disability. Any patient presenting with urinary retention plus perianal/genital anesthesia, bilateral leg pain or weakness, bowel dysfunction, or sexual dysfunction should be evaluated urgently with bedside neuro exam and emergent MRI. Rectal exam to assess anal tone and perianal sensation is essential. Do not delay imaging for other workup; suspect cauda equina and image immediately. If MRI is unavailable, neurosurgery and patient should be informed of the clinical suspicion and alternative imaging (CT with myelography if MRI contraindicated) should be pursued. The window for reversible nerve damage is narrow, and delays in diagnosis and treatment result in permanent morbidity^[3].

BPH Medical Management

Alpha-adrenergic antagonists and 5-alpha reductase inhibitors are the foundation of medical management for benign prostatic hyperplasia. Tamsulosin (an alpha-1A selective agent) is frequently used as first-line therapy and has an onset of action of 48-72 hours; it improves voiding by reducing urethral smooth muscle tone. Finasteride or dutasteride (5-alpha reductase inhibitors) reduce prostate volume over months and are more effective in larger glands; these agents take weeks to months to show effect and are often reserved for long-term management. Combination therapy may be considered in patients with large prostates. Patients discharged with an indwelling catheter should have urology follow-up arranged within 3-5 days for assessment and a planned voiding trial; many will regain spontaneous voiding once medications are optimized and any acute precipitants (infection, medication) are addressed. Surgical options (TURP, laser ablation) are reserved for patients who fail medical management or cannot tolerate long-term catheterization^[2].

Chronic Retention vs Acute

Chronic urinary retention often presents with subtly different clinical and laboratory findings compared to acute retention. Patients with chronic retention may have gradually elevated serum creatinine (due to obstructive nephropathy or overflow incontinence), higher post-void residuals, and dilated bladder on imaging. A large, decompensated bladder on palpation or imaging in the absence of acute symptoms may indicate chronicity. Acute retention, by contrast, typically presents with acute discomfort and abdominal fullness. Renal function should be assessed at baseline and monitored; if significantly elevated creatinine is present, imaging of the kidneys (ultrasound or CT) should evaluate for hydronephrosis and obstructive nephropathy. Urology should evaluate chronically retaining patients for candidacy for voiding trials and determine whether Foley or intermittent catheterization is most appropriate pending urologic intervention^[1].

References

Choong S, Whitfield H, Metha P. Acute urinary retention. BJU Int. 2000;85(2):186-201.
Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the management of benign prostatic hyperplasia. Eur Urol. 2013;64(6):118-140.
Fairley M, Gill B, Carle D, et al. Cauda equina syndrome: Assessment of management outcomes in a retrospective case series. Spinal Cord. 2015;53(8):626-632.
Abarbanel J, Marcus EL. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology. 2007;69(3):436-440.